[Association News] WFA Secretary General Visits HRC Fertility Center in the United States

In July 2024, the World Fertility Industry Alliance (WFA) was invited to visit HRC Fertility Center in the United States, engaging in in-depth exchanges on cutting-edge advancements in reproductive medicine and future collaboration prospects—jointly advancing global reproductive health.

On the afternoon of July 25, 2024, the World Fertility Industry Alliance (WFA) accepted an invitation from HRC Fertility Center (Newport Beach location) in the United States for an in-depth visit and exchange. This visit aimed to strengthen mutual understanding and explore the latest developments and future collaboration opportunities in the field of reproductive medicine. HRC Fertility Center is part of Jinxin Fertility—the first fertility services company listed on the Chinese stock market—and is a large-scale, multi-location reproductive healthcare provider with over 30 years of history. Currently, HRC operates more than ten affiliated centers and employs dozens of full-time physicians, enjoying exceptional brand recognition and an outstanding reputation in the Chinese market. The Newport Beach center visited during this trip is a key component of HRC’s extensive network of clinics.

Laboratory Exchange and Privacy Protection During the visit, Maria, Clinic Manager; Charlotte, Laboratory Director; and two HRC colleagues, Dido and Dan, provided strong support and accompanied the delegation throughout. Charlotte gave a detailed introduction to the laboratory’s development history, state-of-the-art equipment, rigorously standardized management protocols, and remarkable achievements in embryo culture. She noted that HRC’s embryo storage facility still preserves embryos dating back over 20 years—testament to the center’s deep expertise and technical excellence in reproductive medicine.

With 30 years of experience as an embryologist, Charlotte—a seasoned expert—devotes exceptional care and professional rigor to every oocyte and embryo. She implements strict oversight and scientific mentorship for senior embryologists and embryologists alike, ensuring consistently high standards and quality in laboratory operations. During the laboratory tour, Charlotte imposed stringent restrictions on photography—specifically prohibiting images of embryo incubators and her workstation—to fully safeguard patient privacy. This measure powerfully reflects HRC’s unwavering commitment to confidentiality and its rigorous, patient-centered ethos.

Expert Interaction and Serendipitous Connections Additionally, the delegation had the privilege of meeting several renowned reproductive specialists at HRC Fertility Center—including a distinguished white-haired gentleman whose appearance strikingly resembles Albert Einstein, and Dr. Lisa, a Columbia University graduate. Coincidentally, one delegation member is set to pursue academic studies at Columbia University—an unexpected alumni connection with Dr. Lisa—that added a uniquely personal and meaningful dimension to this visit.

HRC Center Environment and Development HRC Fertility Center (Newport Beach location) ranks among the largest of its kind in the United States: it features six dedicated embryo transfer rooms, boasts advanced facilities and luxurious interior design, and offers an overall environment that is both comfortable and welcoming. According to available information, this center was personally founded by Mr. Deng Xuyang—the founder of Mengmei Life—whose vision, dedication, and expertise have shaped it into a landmark achievement in reproductive medicine.

Future Outlook for the HRC Laboratory This visit not only strengthened the friendly relationship between the World Fertility Industry Alliance (WFA) and HRC Fertility Center but also laid a solid foundation for deeper collaboration in reproductive medicine. Moving forward, both parties will maintain close communication and cooperation, jointly driving innovation and advancement in reproductive medical technologies—and bringing hope and blessings to more families worldwide.

This article is a public-information summary published by WFA. It is intended for industry, media and the general public, and does not constitute medical or investment advice.